Bausch Health Companies | Les Charges D'Exploitation



Operating Expenses Changement Date
Amgen USD 6.86B 85M 2025-03
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bausch Health Companies USD 1.98B 32M 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Danaher USD 4.46B 655M 2025-03
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
Novo Nordisk 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Zoetis USD 1.59B 71M 2024-12



Bausch Health Companies Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.